Tarsus Pharmaceuticals Inc header image

Tarsus Pharmaceuticals Inc

TARS

Equity

ISIN null / Valor 57410241

NASDAQ (2026-02-19)
USD 65.54+3.59%

Tarsus Pharmaceuticals Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Tarsus Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative treatments for diseases with significant unmet medical needs. The company has gained recognition for its FDA-approved product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, which is the first treatment specifically approved for Demodex blepharitis, a condition affecting millions of patients. Tarsus is committed to expanding its pipeline with a focus on addressing large-scale diseases that currently have limited treatment options, thereby aiming to improve patient outcomes across various therapeutic areas.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

32.3%1Y
323%3Y
69.1%5Y

Performance

48.6%1Y
58.3%3Y
61.4%5Y

Volatility

Market cap

2782 M

Market cap (USD)

Daily traded volume (Shares)

841,755

Daily traded volume (Shares)

1 day high/low

57.03 / 53.92

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Halma PLC
Halma PLC Halma PLC Valor: 387465
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%GBP 39.24
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc Sarepta Therapeutics Inc Valor: 19028527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 18.59
Computacenter PLC
Computacenter PLC Computacenter PLC Valor: 27035417
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.99%GBP 30.62
Kainos Group PLC
Kainos Group PLC Kainos Group PLC Valor: 28842999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%GBP 7.12
F5 Inc
F5 Inc F5 Inc Valor: 812258
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.54%USD 279.19
Trainline Plc
Trainline Plc Trainline Plc Valor: 48455453
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.95%GBP 2.03
Oxford Instruments PLC
Oxford Instruments PLC Oxford Instruments PLC Valor: 399430
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%GBP 26.15
Booking Holdings Inc
Booking Holdings Inc Booking Holdings Inc Valor: 40656108
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.15%USD 4,007.45
FDM Group (Holdings) PLC
FDM Group (Holdings) PLC FDM Group (Holdings) PLC Valor: 24732036
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.05%GBP 1.43
Geron Corporation (Delaware)
Geron Corporation (Delaware) Geron Corporation (Delaware) Valor: 145973
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 1.92